WELCOME TO GROUP OTONKOSKI’S PAGES

Otonkoski lab is interested in nuclear reprogramming and genome editing, and how these can be applied to understand mechanisms behind pancreatic beta-cell failure leading to diabetes. We also operate a Core Facility service, the Biomedicum Stem Cell Centre (BSCC).
Read more

Research highlights

@OtonkoskiL

M/S MetaStem taking off for our yearly Summit https://t.co/H7VYWrxli5

Extremely happy to see our "Mature Beta" project finally published @NatureBiotech🥳🤩😊This is the result of a fantast… twitter.com/i/web/status/1…